Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Leukemia Année : 2020

Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

(1) , , (2) , (3) , , , (4) , , , , , (5) , (6) , (7, 8) , , , (9) , , , ,
1
2
3
4
5
6
7
8
9

Dates et versions

hal-03604943 , version 1 (10-03-2022)

Identifiants

Citer

Alessandro Rambaldi, Alessandra Iurlo, Alessandro M. Vannucchi, Richard Noble, Nikolas Von Bubnoff, et al.. Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study. Leukemia, 2020, 34 (8), pp.2234-2237. ⟨10.1038/s41375-020-0735-y⟩. ⟨hal-03604943⟩

Collections

U-PICARDIE HEMATIM
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More